Taylor Frigon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Taylor Frigon Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19,859	Closed	-$1.02M	–	86
2023 Q4	$1.02M	Sell	19,859 -109	-0.5%	-$5.72K	0.51%	79
2023 Q3	$1.16M	Buy	19,968 +535	+3%	+$32.8K	0.64%	74
2023 Q2	$1.24M	Sell	19,433 -32	-0.2%	-$2.15K	0.61%	80
2023 Q1	$1.35M	Sell	19,465 -181	-0.9%	-$12.8K	0.74%	62
2022 Q4	$1.41M	Sell	19,646 -1,468	-7%	-$111K	0.8%	48
2022 Q3	$1.5M	Sell	21,114 -77	-0.4%	-$5.59K	0.78%	50
2022 Q2	$1.63M	Sell	21,191 -203	-0.9%	-$15.5K	0.85%	45
2022 Q1	$1.56M	Sell	21,394 -206	-1%	-$13.8K	0.58%	64
2021 Q4	$1.35M	Buy	21,600 +482	+2%	+$28.3K	0.42%	83
2021 Q3	$1.25M	Buy	21,118 +723	+4%	+$47.6K	0.4%	81
2021 Q2	$1.36M	Buy	20,395 +1,639	+9%	+$107K	0.43%	67
2021 Q1	$1.18M	Buy	18,756 +487	+3%	+$30.3K	0.37%	68
2020 Q4	$1.13M	Sell	18,269 -80	-0.4%	-$4.92K	0.37%	69
2020 Q3	$1.11M	Buy	18,349 +291	+2%	+$17.5K	0.49%	62
2020 Q2	$1.06M	Buy	18,058 +428	+2%	+$25.6K	0.53%	61
2020 Q1	$983K	Sell	17,630 -182	-1%	-$11.1K	0.77%	51
2019 Q4	$1.14M	Buy	+17,812	New	+$1.02M	0.79%	56

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Taylor Frigon Capital Management's BMY Position: Q1 2024 in Review

Taylor Frigon Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 19,859 shares — an estimated $1.02M sold.

Taylor Frigon Capital Management first reported a position in BMY in Q4 2019 and held it in 17 quarters. The position peaked at $1.63M in Q2 2022. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Taylor Frigon Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Taylor Frigon Capital Management sold 19,859 Bristol-Myers Squibb shares in Q1 2024, an estimated $1.02M.
Taylor Frigon Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 17 quarters.
Taylor Frigon Capital Management's Bristol-Myers Squibb position peaked at $1.63M in Q2 2022.
2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Taylor Frigon Capital Management's 13F filing for Q1 2024, filed 19 Apr 2024.